The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Market Size Is Forecasted For The Candida Infection Testing Market By 2030 Based On Its 2026 Value?
The candidiasis therapeutics market has observed consistent expansion over recent years. Projections indicate its size will increase from $3.29 billion in 2025 to $3.4 billion in 2026, progressing at a compound annual growth rate (CAGR) of 3.5%. This market’s historical growth can be linked to several factors, including the increasing prevalence of immunocompromised patient populations, a rising incidence of hospital-acquired fungal infections, the widespread use of broad-spectrum antibiotics, the availability of established antifungal drug classes, and the general growth of hospital-based infectious disease care.
The candidiasis therapeutics market is projected to experience consistent expansion in the coming years. Its valuation is anticipated to reach $4.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. This expansion over the forecast period is driven by several factors, including escalating research into new antifungal drug classes, heightened awareness regarding antifungal resistance management, increased adoption of outpatient antifungal treatments, a greater emphasis on pediatric candidiasis therapies, and rising investments in the development of infectious disease drugs. Key trends foreseen during this period encompass the growing development of targeted antifungal treatments, an increased focus on prompt and precise diagnosis, the expanding application of combination antifungal regimens, the wider availability of oral and systemic treatment alternatives, and improved surveillance of drug resistance patterns.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19356&type=smp
Which Growth Drivers Are Expected To Support The Candida Infection Testing Market Forward?
The increasing number of clinical trials is anticipated to drive the expansion of the candidiasis therapeutics market in the coming years. Clinical trials represent investigative studies undertaken to assess the safety and efficacy of new medical treatments, interventions, drugs, or devices in humans. These trials are instrumental in the development of candidiasis therapeutics, providing a systematic and rigorous framework to evaluate the safety and effectiveness of potential therapies. For instance, data from May 2023, published by ClinicalTrials.gov, an arm of the National Institutes of Health (NIH), a US-based government agency responsible for medical research, indicated that approximately 437,533 clinical trials were registered in 2023. This figure compares to 399,499 registered studies in 2022 across all 50 states of the United States and 221 countries. Consequently, the growing volume of clinical trials is a key factor propelling the growth of the candidiasis therapeutics market.
Which Segment Divisions Form The Structure Of The Candida Infection Testing Market?
The candida infection testing market covered in this report is segmented –
1) By Type: Invasive Candidiasis, Candidemia
2) By Test Type: Vaginal pH Test, Nucleic Acid Amplification Testing (NAAT), Microbiome Test
3) By Application: Hospital, Laboratory
Subsegments:
1) By Invasive Candidiasis: Tissue Biopsy Testing, Urine Culture Testing, Blood Culture Testing
2) By Candidemia: Blood Tests, Serological Testing, Molecular Testing
What Trends Are Affecting The Candida Infection Testing Market Dynamics?
Major companies within the Candidiasis Therapeutics market are concentrating their efforts on devising advanced treatments, such as echinocandin antifungal therapy, to boost treatment effectiveness, lessen resistance, and improve results for patients battling invasive and systemic Candida infections. Echinocandin antifungal therapy is a category of medications that functions by hindering ß-(1,3)-D-glucan synthesis in fungal cell walls, proving effective against severe invasive Candida infections. Illustratively, in March 2023, Cidara Therapeutics Inc., a US-based biotech firm, in collaboration with Melinta Therapeutics, a US-based biopharmaceutical company, secured U.S. FDA approval for REZZAYO (rezafungin for injection). This approval is for the management of candidemia and invasive candidiasis in adults who have few or no other treatment alternatives. REZZAYO stands out as a pioneering once-weekly echinocandin antifungal, marking the first novel treatment available for these infections in more than a decade.
Which Organizations Are Involved In The Candida Infection Testing Market?
Major companies operating in the candida infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Cepheid, Randox Laboratories Ltd., Meridian Bioscience Inc., DiaSorin S.p.A., Sekisui Diagnostics LLC, Enzo Biochem Inc., T2 Biosystems Inc., Aidian Oy, SafeCare LLC, CHROMagar, HK Biotek Inc., Health Testing Centers LLC, Accesa Labs LLC, Private MD Labs LLC
Access The Complete Candida Infection Testing Market Report:
https://www.thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report
Which Region Stands As The Largest Contributor To The Candida Infection Testing Market?
North America was the largest region in the candida infection testing market in 2025. The regions covered in the candida infection testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Candida Infection Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=19356&type=smp
Browse Through More Reports Similar to the Global Candida Infection Testing Market 2026, By The Business Research Company
Cancer Profiling Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report
Cancer Biomarker Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report
Cancer Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model